1 |
Cutaneous melanoma in Birt-Hogg-Dub syndrome: part of the clinical spectrum?.Br J Dermatol. 2018 Feb;178(2):e132-e133. doi: 10.1111/bjd.15937. Epub 2018 Jan 7.
|
2 |
Genetically diagnosed Birt-Hogg-Dub syndrome and familial cerebral cavernous malformations in the same individual: a case report.Fam Cancer. 2017 Jan;16(1):139-142. doi: 10.1007/s10689-016-9928-y.
|
3 |
The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dub syndrome is required for murine B-cell development.Blood. 2012 Aug 9;120(6):1254-61. doi: 10.1182/blood-2012-02-410407. Epub 2012 Jun 18.
|
4 |
Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity. Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3706-15. doi: 10.1073/pnas.1607592113. Epub 2016 Jun 14.
|
5 |
Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dub tumour suppressor gene (FLCN).Oncogene. 2014 Feb 20;33(8):956-65. doi: 10.1038/onc.2013.27. Epub 2013 Feb 18.
|
|
|
|
|
|
|